RJA
TVTY

Raymond James & Associates’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Raymond James & Associates’s Portfolio TVTY Stock Details TVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,722
Closed -$570K – 4292
2022
Q1 		$570K Buy
+17,722
New +$479K ﹤0.01% 2998
2020
Q1 		– Sell
-14,091
Closed -$287K – 3791
2019
Q4 		$287K Buy
+14,091
New +$264K ﹤0.01% 3108
2019
Q3 		– Sell
-66,503
Closed -$1.09M – 3755
2019
Q2 		$1.09M Buy
+66,503
New +$1.28M ﹤0.01% 2161
2019
Q1 		– Sell
-17,290
Closed -$429K – 3748
2018
Q4 		$429K Sell
17,290
-1,435
-8% -$47.7K ﹤0.01% 2638
2018
Q3 		$602K Sell
18,725
-564
-3% -$19.2K ﹤0.01% 2582
2018
Q2 		$679K Buy
19,289
+351
+2% +$13K ﹤0.01% 2475
2018
Q1 		$751K Buy
18,938
+869
+5% +$33.7K ﹤0.01% 2319
2017
Q4 		$660K Buy
18,069
+1,158
+7% +$43.9K ﹤0.01% 2379
2017
Q3 		$690K Buy
16,911
+11,877
+236% +$460K ﹤0.01% 2300
2017
Q2 		$201K Buy
+5,034
New +$168K ﹤0.01% 2985

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Raymond James & Associates's TVTY Position: Q2 2022 in Review

Raymond James & Associates sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 17,722 shares — an estimated $570K sold.

Raymond James & Associates first reported a position in TVTY in Q2 2017 and held it in 10 quarters. The position peaked at $1.09M in Q2 2019. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Raymond James & Associates reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 17,722 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $570K.
  • Raymond James & Associates first reported a position in Tivity Health, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
  • Raymond James & Associates's Tivity Health, Inc. Common Stock position peaked at $1.09M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.